WE International
VC Fund
Liège, Belgium
WE International is a financial firm that provides an array of loans, funding, acquisition, and investment services.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 26%
Last updated:
For AI agents: llms.txt
Industries WE International invests in
Stages WE International invests in
Countries WE International invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $2.2M–$43M
- Series A
- $10M–$57M
- Venture - Series Unknown
- $16M–$251M
Investment Focus
Industry
- Health Care 7 (30%)
- Energy 6 (26%)
- Biotechnology 5 (22%)
- Manufacturing 4 (17%)
- Medical Device 3 (13%)
Stage
- Seed 5 (22%)
- Series A 4 (17%)
- Venture - Series Unknown 4 (17%)
- Funding Round 3 (13%)
- Post-IPO Debt 2 (9%)
Country
- Belgium 13 (57%)
- United States 2 (9%)
- France 1 (4%)
- Germany 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Laurence Glautier
General Manager
|
General Manager | Total investments: 0 | Find email | |
Olivier Bouchat
Executive
|
Executive | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
e-peas
|
e-peas is a disruptive semiconductor company that enables the seamless operation of all connected nodes. The company is developing ultra-low-power high performances circuits such as energy harvester interfaces and microcontrollers that help companies make their IoT devices smarter and more energy-efficient by either prolonging battery life ormaking the devices live forever. e-peas also develops energy harvesting solutions which extend rechargeable batteries' life of portable devices by harvesting energy from solar, thermal, vibration, radiofrequency, and other sources. These solutions help industries to build products that free users and industries from a burden of replacing non-rechargeable batteriesThe company was founded in 2014 and is headquartered in Mont-saint-guibert, Brabant Wallon, Belgium. | $21.9M / Venture - Series Unknown / Jul 08, 2026 | |
neuroClues
|
PCUBE-LAB are developing NeuroClues, a solution to instantaneously quantify your clinical exam based on a portable laboratory using eye tracking. | $11.5M / Series A / Apr 06, 2026 | |
VolitionRx
|
Volition is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid which is an indication that disease ispresent.As cancer screening programs become more and more widespread, its products aim to help to diagnose a range of cancers quickly, simply, accurately, and cost-effectively. Early diagnosis has the potential to not only prolong the life of patients but also to improve their quality of life.Volition's research and development activities are currently centered in Belgium, with additional offices in London, Texas, and Singapore, as the company focuses on bringing its diagnostic products to market first in Europe, then in the U.S. and worldwide. | $2.3M / Grant / Mar 31, 2026 | |
Vertical Compute
|
Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings. | $42.9M / Seed / Mar 04, 2026 | |
Enodia Therapeutics
|
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases. | $24.2M / Seed / Jan 08, 2026 | |
Ion Beam Applications
|
Ion Beam Applications is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticalssegment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. | $155.8M / Post-IPO Debt / Nov 19, 2025 | |
Sunrise
|
Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems. | $29.2M / Sep 25, 2025 | |
John Cockerill Hydrogen
|
John Cockerill Hydrogen is a major global company that specializes in green hydrogen technology, particularly innovative alkaline electrolysers used to produce hydrogen. | $134.7M / Jun 24, 2025 | |
ARK Capture Solutions
|
ARK Capture Solutions is a cleantech company that specializes in decarbonization solutions to record low energy consumption. | $2.4M / Pre-Seed / Mar 25, 2025 | |
mi2-factory
|
mi2-factory offers high energy ion implantation and EFII-technology based implantation services. | $10.4M / Jan 21, 2025 | |
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does WE International invest in?
WE International invests primarily in Health Care, Energy and Biotechnology startups, most often at Seed and Series A stage. Most of the 23 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is WE International's check size?
WE International typically joins rounds of $2.2M–$43M at Seed, $10M–$57M at Series A and $16M–$251M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds WE International participates in.
How do I contact WE International?
Public channels for WE International include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at WE International?
The team at WE International includes Laurence Glautier (General Manager) and Olivier Bouchat (Executive). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
